Enhancing metabolism using GLP-1 receptor agonists offers a solid theoretical basis for enhancing reproductive outcomes, given that obesity and insulin resistance affect follicular maturation, ovulation, egg quality, and endometrial receptivity [23]. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.